Pathologically, LSZ inhibits AD-induced accumulation of Aβ plaques, hyperphosphorylation of Tau, cell death, and NF-κB-mediated inflammation, and promotes antioxidative gene expression in the brains of APP/PS1 mice (Figure 8). The gene discussed is NFKB1; the disease is Alzheimer disease.